Prognostic stratification of patients with chronic systolic heart failure using biomarkers and Doppler echocardiography.Ghio S, Alessandrino G, Albertini R, Klersy C, Girardi B, Maggi G, Pazzano AS, Raineri C, Scelsi L, Visconti LO. J Cardiovasc Med. 2014 Jun;15(6):470-5.
ISMAR-study presentation: in-hospital epidemiology and clinical management of respiratory and cardiac comorbidities in cardiac and respiratory disease units. Tramarin R, Polverino M, Volterrani M, Girardi B, Chimini C, Ambrosino N, De Benedetto F, Proto C. Multidiscip Respir Med. 2014 May 20;9(1):28.
Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. Ghio S, Temporelli PL, Klersy C, Simioniuc A, Girardi B, Scelsi L, Rossi A, Cicoira M, Tarro Genta F, Dini FL. Eur J Heart Fail. 2013 Apr;15(4):408-14.
Validation of Seattle Heart Failure Model for mortality risk prediction in patients treated with cardiac resynchronization therapy. Regoli F, Scopigni F, Leyva F, Landolina M, Ghio S, Tritto M, Calò L, Klersy C, Auricchio A; collaborative study group. Eur J Heart Fail. 2013 Feb;15(2):211-20.
Dalla Best Clinical Practise all’appropriatezzza e sostenibilità dell’impiego di ACE-I e sartanici- Vascular Health Trends; anno 5, numero 2 – settembre 2010
